Drug Profile
MHS G
Alternative Names: Morihepamin GLatest Information Update: 08 Nov 1995
Price :
$50
*
At a glance
- Originator Roussel-Morishita
- Class Amino acids; Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatic encephalopathy
Most Recent Events
- 08 Nov 1995 Discontinued-preregistration for Hepatic encephalopathy in Japan (Unknown route)
- 01 Nov 1994 Preregistration for Hepatic encephalopathy in Japan (Unknown route)